This subunit liquid vaccine should compose of purified Vi capsular polysaccharide of salmonella typhi strain. Each single human dose of 0.5ml should contain 25mic.g of the Vi polysaccharide of S.typhi to be administered

• Country: Sri Lanka
• Summary: This subunit liquid vaccine should compose of purified Vi capsular polysaccharide of salmonella typhi strain. Each single human dose of 0.5ml should contain 25mic.g of the Vi polysaccharide of S.typhi to be administered
• LKT Ref No: 76375774
• Deadline: 05 Jan 2023
• Financier: Self Financed
• Purchaser Ownership: Public
• Tender Value: Refer Document
• Notice Type: Tender
• Document Ref. No.: DHS/RP/005/2023
• Purchaser's Detail:

Purchaser : STATE PHARMACEUTICALS CORPORATION OF SRI LANKA
No.75, Sir Baron Jayathilake Mawatha, Colombo 01, Sri Lanka. Telephone :+94 (0)11 2320356-9, Fax :+94 (0)11 2447118
Email :chairman@spc.lk

• Description:
• This subunit liquid vaccine should compose of purified Vi capsular polysaccharide of salmonella typhi strain. Each single human dose of 0.5ml should contain 25mic.g of the Vi polysaccharide of S.typhi to be administered intramuscularly
• Documents:

 Tender Notice